FIORILLO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 2.063
AS - Asia 1.877
EU - Europa 1.059
SA - Sud America 527
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
AN - Antartide 1
Totale 5.664
Nazione #
US - Stati Uniti d'America 1.993
SG - Singapore 910
BR - Brasile 416
CN - Cina 394
IT - Italia 287
UA - Ucraina 237
VN - Vietnam 221
DE - Germania 202
HK - Hong Kong 80
SN - Senegal 71
SE - Svezia 65
KR - Corea 62
FI - Finlandia 50
AT - Austria 46
AR - Argentina 45
CA - Canada 39
FR - Francia 39
TR - Turchia 39
IN - India 35
GB - Regno Unito 29
ZA - Sudafrica 26
RU - Federazione Russa 25
IQ - Iraq 23
MX - Messico 22
BD - Bangladesh 20
EC - Ecuador 17
JP - Giappone 16
ID - Indonesia 14
NL - Olanda 14
BE - Belgio 13
MA - Marocco 13
PL - Polonia 13
PE - Perù 9
PK - Pakistan 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
CO - Colombia 7
BG - Bulgaria 6
BO - Bolivia 6
CL - Cile 6
ES - Italia 6
PY - Paraguay 6
AU - Australia 5
CZ - Repubblica Ceca 5
IR - Iran 5
KE - Kenya 5
UY - Uruguay 5
UZ - Uzbekistan 5
EU - Europa 4
JM - Giamaica 4
JO - Giordania 4
EG - Egitto 3
IL - Israele 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
TH - Thailandia 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
MY - Malesia 2
PH - Filippine 2
RO - Romania 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
IE - Irlanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.664
Città #
Singapore 337
Chandler 292
Dallas 191
Jacksonville 137
Boardman 134
New York 134
Beijing 119
Ashburn 98
Ho Chi Minh City 85
San Mateo 83
Hong Kong 79
Dakar 71
Dearborn 67
Rende 63
Seoul 62
Hanoi 53
Shanghai 53
Hefei 47
Lawrence 44
Roxbury 44
São Paulo 39
Helsinki 35
Munich 33
Los Angeles 32
Brooklyn 31
Vienna 28
Izmir 26
Florence 24
Des Moines 21
Ottawa 21
Seattle 21
The Dalles 20
Catanzaro 18
Rio de Janeiro 18
Cosenza 15
Tokyo 15
Santa Clara 14
Brussels 13
Cambridge 13
Frankfurt am Main 13
Inglewood 13
Baghdad 12
San Francisco 12
Turku 12
Columbus 11
Guangzhou 11
Ogden 11
Porto Alegre 11
Biên Hòa 10
Chennai 10
Hanover 10
Johannesburg 10
Warsaw 10
Wilmington 10
Boston 9
Da Nang 9
Hải Dương 9
Stockholm 9
Naples 8
Rome 8
Ann Arbor 7
Belo Horizonte 7
Bremen 7
Catania 7
Falkenstein 7
Guarulhos 7
Haiphong 7
Mexico City 7
Milan 7
Toronto 7
Amsterdam 6
Atlanta 6
Bari 6
Council Bluffs 6
Dhaka 6
Grafing 6
Guayaquil 6
London 6
Manchester 6
Montreal 6
Ninh Bình 6
Pune 6
Contagem 5
Curitiba 5
Juiz de Fora 5
Lima 5
Modugno 5
Norwalk 5
Palermo 5
Phoenix 5
Tashkent 5
Tianjin 5
Uberlândia 5
Wuhan 5
Amman 4
Ankara 4
Brno 4
Buenos Aires 4
Goiânia 4
Hortolândia 4
Totale 3.074
Nome #
Polyunsaturated Fatty Acids and their Role in the Diet of Cancer Patients: An Overview 186
Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism 181
5-(Carbamoylmethylene)-oxazolidin-2-ones as a Promising Class of Heterocycles Inducing Apoptosis Triggered by Increased ROS Levels and Mitochondrial Dysfunction in Breast and Cervical Cancer 166
Bergamot (citrus bergamia risso) flavonoids and their potential benefits in human hyperlipidemia and atherosclerosis: An overview 160
17-Hydroxyprogesterone/Progesterone Receptor B Signalling Disrupts the Metabolic Reprogramming in Breast Cancer Cell Lines 159
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 157
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 150
Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway 145
Enhanced cellular uptake by "pharmaceutically oriented devices" of new simplified analogues of Linezolid with antimicrobial activity 143
Antibacterial activity of new Beta-lactam compounds 138
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 138
Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs) 137
A Picrocrocin-Enriched Fraction from a Saffron Extract Affects Lipid Homeostasis in HepG2 Cells through a Non-Statin-like Mode 134
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 129
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 128
Characterization of new mitochondrial carriers in Drosophila melanogaster”. 126
Sericin/Poly(ethylcyanoacrylate) Nanospheres by Interfacial Polymerization for Enhanced Bioefficacy of Fenofibrate: In Vitro and In Vivo Studies 123
ERRα PATHWAY AND ENDOCRINE RESISTANCE ON BREAST CANCER: CHOLESTEROL AND MEVALONATE INVOLVEMENT 121
Estrogen Related Receptor α (ERRα) A Promising Target for the Therapy of Adrenocortical Carcinoma (ACC). 118
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 112
Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy 108
Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast 108
New insights about the structural rearrangements required for substrate translocation in the bovine mitochondrial oxoglutarate carrier 102
Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production 97
Thioalbamide, a thioamidated peptide from Amycolatopsis alba, affects tumor growth and stemness by inducing metabolic dysfunction and oxidative stress 96
GENOMICS-BASED DISCOVERY AND ANTICANCER ACTIVITY ASSESSMENT OF NEW THIOVIRIDAMIDE-LIKE MOLECULES PRODUCED BY ACTINOBACTERIA 89
Doxycycline, Azithromycin and vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs) 89
Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase 89
New insights into cholesterol-mediated ERRα activation in breast cancer progression and pro-tumoral microenvironment orchestration 84
Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells 84
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple‐negative breast cancer (TNBC) cells 84
"Energetic" cancer stem cells (e-CSCs): A new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy 83
Hypocholesterolaemic activity of 3-hydroxy-3-methyl-glutaryl flavanones enriched fraction from bergamot fruit (Citrus bergamia): "In vivo" studies 82
Oxazolidinones-mediated mitochondrial dysfunction promotes cell death and cancer stemness inhibition in breast and cervical cancer 74
FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity 74
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 74
Two functionally different mitochondrial phosphate carriers support Drosophila melanogaster OXPHOS throughout distinct developmental stages 73
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 72
Mass Spectrometry-Based Proteomic Approach in Oenococcus oeni Enological Starter 71
Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via "differentiation-based nano-therapy" 71
Multifunctional Microspheres Based on D-Mannose and Resveratrol for Ciprofloxacin Release 69
Sntesi ed attività antimicrobica di nuovi derivati b-lattamici 67
The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment 66
New Oxazolidin-2-ones with antimicrobial activity 62
New simplified analogues of linezolid with antimicrobial activity. 62
New Oxazolidin-2-ones of antimicrobial activity 61
Impact of COVID-19 Lockdown on Metabolic/Inflammatory Profile in Adolescents: Cellular Studies and Predictive Biomarkers 60
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 59
Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells 59
New β-Lactam derivatives: synthesis and antimicrobial properties. 58
Exploiting Glycyrrhiza glabra L. (Licorice) Flavanones: Licoflavanone’s Impact on Breast Cancer Cell Bioenergetics 57
Merging fusogenic DOPE and a tumour targeted self-assembling biopolymer: Smart hybrid liposomes for drug vectorization in cancer therapy 55
Thioalbamide inhibits FoF1-ATPase in breast cancer cells and reduces tumor proliferation and invasiveness in breast cancer in vivo models 55
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer 54
The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy 52
High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy 51
Novel CD44-Targeted Albumin Nanoparticles: An Innovative Approach to Improve Breast Cancer Treatment 47
Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling 45
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 41
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity 41
Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia 40
Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs) 38
Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy 33
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics 29
Totale 5.816
Categoria #
all - tutte 35.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 28 3 53 17 28 7 24
2021/2022466 9 61 2 20 45 9 2 98 21 3 68 128
2022/2023774 100 80 21 79 103 55 13 111 95 27 59 31
2023/2024595 67 20 35 16 31 183 21 29 62 33 16 82
2024/20251.247 86 149 19 74 79 74 90 73 192 88 112 211
2025/20262.045 418 237 346 287 582 175 0 0 0 0 0 0
Totale 5.816